Coherent ( COHR ) announced it will join the S&P 500, effective Monday, March 23. The index addition may lead to increased demand for the company’s shares from index-tracking funds and ETFs. More on Coherent Coherent Corp. (COHR) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript Why Coherent Is A Strong Buy After Rising Nearly 15% Coherent: A Compelling Opportunity ...
Coherent ( COHR ) announced it will join the S&P 500, effective Monday, March 23. The index addition may lead to increased demand for the company’s shares from index-tracking funds and ETFs. More on Coherent Coherent Corp. (COHR) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript Why Coherent Is A Strong Buy After Rising Nearly 15% Coherent: A Compelling Opportunity For Patient Investors Vertiv, Lumentum, Coherent, and EchoStar are new additions to the S&P 500 Credo rises, Lumentum, Coherent fall, as Broadcom puts weight behind attached copper
loanDepot ( NYSE: LDI ) on Monday said it has launched a new wholesale lending channel aimed at mortgage brokers, led by Dan Peña, President of Partnership Lending. The channel, built on the company’s proprietary mortgage platform, offers competitive pricing, a full range of products, and dedicated broker support, combining digital convenience with direct account management. LoanDepot said the ini...
loanDepot ( NYSE: LDI ) on Monday said it has launched a new wholesale lending channel aimed at mortgage brokers, led by Dan Peña, President of Partnership Lending. The channel, built on the company’s proprietary mortgage platform, offers competitive pricing, a full range of products, and dedicated broker support, combining digital convenience with direct account management. LoanDepot said the initiative complements its existing direct-to-consumer, retail, joint venture, and servicing businesses. Mortgage industry veteran Matt Mancasola has returned to loanDepot as VP of wholesale lending to oversee the expansion. LDI -2.25% premarket to $1.73. Source: Press Release More on loanDepot loanDepot: One Winner From Mortgage-Spread Compression loanDepot: A 'Buy' With External And Internal Tailwinds (Rating Upgrade) Real estate tech stocks gap up amid Trump's housing relief push Seeking Alpha’s Quant Rating on loanDepot Historical earnings data for loanDepot
Anyone viewing the island has been warned by the agents to "take care and caution throughout inspections and to remain vigilant at all times for their own personal safety", given the potential risks "including the access route, terrain and tidal conditions".
Anyone viewing the island has been warned by the agents to "take care and caution throughout inspections and to remain vigilant at all times for their own personal safety", given the potential risks "including the access route, terrain and tidal conditions".
RBC Capital Markets is maintaining a constructive outlook for U.S. equities despite rising geopolitical uncertainty tied to tensions in the Middle East, arguing that it is too early to meaningfully alter its market assumptions. In its latest market pulse report, the investment bank reiterated a rolling 12-month price target of 7,750 for the S&P 500 ( SP500 ), which implies roughly 13% upside from ...
RBC Capital Markets is maintaining a constructive outlook for U.S. equities despite rising geopolitical uncertainty tied to tensions in the Middle East, arguing that it is too early to meaningfully alter its market assumptions. In its latest market pulse report, the investment bank reiterated a rolling 12-month price target of 7,750 for the S&P 500 ( SP500 ), which implies roughly 13% upside from the index’s February month-end close. The benchmark index is currently hovering near 6,750, placing it within range of RBC’s longer-term projections. The firm’s forecast is broadly aligned with the current bottom-up consensus estimate for 2026 S&P 500 earnings per share of $316, representing expected EPS growth of about 13.5%. RBC believes corporate earnings expansion—rather than multiple expansion—will be the primary driver of further market gains. Analysts at the bank expect the equity market to benefit from several supportive macroeconomic trends over the next year, including resilient economic growth, moderating inflation, and a gradual easing cycle from the Federal Reserve. Together, those factors could provide a foundation for another year of solid equity performance. However, RBC acknowledged that escalating tensions involving Iran introduce an additional layer of uncertainty for investors. The firm said markets are currently in a “discovery process,” attempting to gauge how long the conflict might last, how high oil prices could climb, and what broader economic effects may emerge. While RBC said the situation requires careful monitoring, it emphasized that it is premature to adjust forecasts. For now, the bank expects equities to eventually resume the trajectory they were following prior to the latest geopolitical developments, though a prolonged conflict or sustained surge in oil prices could eventually force revisions to its outlook. Market Tracking ETFs: ( DIA ), ( DDM ), ( DOG ), ( DXD ), ( SDOW ), ( SPY ), ( VOO ), ( IVV ), ( RSP ), ( SSO ), ( UPRO ), ( SH ), (...
Pascal Le Segretain/Getty Images News Wells Fargo has resumed its coverage of media giants Netflix ( NFLX ) and Paramount Skydance ( PSKY ) following the months-long bidding war for the assets of Warner Bros. Discovery ( WBD ). The research firm views the final outcome as a "pyrrhic victory" for Paramount and expects the Netflix stock to recoup losses in the days ahead. Wells Fargo noted that the ...
Pascal Le Segretain/Getty Images News Wells Fargo has resumed its coverage of media giants Netflix ( NFLX ) and Paramount Skydance ( PSKY ) following the months-long bidding war for the assets of Warner Bros. Discovery ( WBD ). The research firm views the final outcome as a "pyrrhic victory" for Paramount and expects the Netflix stock to recoup losses in the days ahead. Wells Fargo noted that the combined Paramount and WBD would generate much of its earnings from an increasingly challenged linear ecosystem and faces the crucial challenge of deleveraging while investing in an increasingly crowded video market. "PSKY's successful effort to capture WBD may leave equity holders in a precarious spot… While PSKY is stronger with WBD, shareholders are highly exposed to valuation… If PSKY derates (say on recession or AI), then equity holders get compressed," the research firm said Monday. However, they are optimistic about the streaming prospects of Paramount+ and HBO, which would make up about 3% of U.S. TV engagement time, still below Disney ( DIS ) and Netflix. "We think culturally PSKY is creative-centric and will be an environment for HBO to thrive. The near-term risk is that combining the 2 services, which is what needs to happen to reduce churn, will also cannibalize some revenue," Wells Fargo said. On Netflix, the research firm believes the streaming pioneer will be aggressive with content growth and capital allocation, especially in sports. "We viewed WBD as a form of accelerating content investment: save on future years' spend by pulling it forward into 1 big deal for known IP + brands like HBO. Still, we think WBD was NFLX's opportunistic Plan B, and now it's back to Plan A: invest for growth," Wells Fargo said. With an NFL renewal upcoming, Wells Fargo thinks Netflix could go for 10-20 games per season at an annual cost of ~$500M to $1B. Paramount was resumed at "underweight." Before the rating restriction, Wells had assigned it "equal weight." Netflix was resum...
Shortly after the opening bell, we will be selling 300 shares of Cisco Systems at roughly $77.12. Following the trade, Jim Cramer's Charitable Trust will own 600 shares of CSCO, decreasing its weighting in the portfolio to about 1.25% from 1.85%. We are making one sale on Monday to boost our cash position, as stock futures have cut their losses by roughly half from Sunday evening's lows. The move ...
Shortly after the opening bell, we will be selling 300 shares of Cisco Systems at roughly $77.12. Following the trade, Jim Cramer's Charitable Trust will own 600 shares of CSCO, decreasing its weighting in the portfolio to about 1.25% from 1.85%. We are making one sale on Monday to boost our cash position, as stock futures have cut their losses by roughly half from Sunday evening's lows. The move coincided with volatility in the oil markets, as U.S. crude benchmark West Texas Intermediate rallied to about $119 a barrel before dropping to about $102. The move off the overnight highs followed reports that the Group of 7 was discussing the release of oil reserves. In Jim's Sunday piece , he compared the current moment to what happened in 2022, when oil and inflation surged, causing the S & P 500 to fall more than 20% from its highs. Jim's story mentions a hesitancy to sell Monday because the market is nearing oversold levels, but we want to make the portfolio even more prepared for more declines in case oil rallies back to $119 and the market drops back to last night's lows. We're letting go of some shares of Cisco Systems, securing a profit of about 13% on stock bought last July in the process. Its double-digit order growth in the recent quarter was a great sign of demand, but rising memory prices will dip into its gross margins, potentially capping earnings per share upside in future quarters. (Jim Cramer's Charitable Trust is long CSCO. See here for a full list of the stocks.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY O...
Leestat Global transfers of major weapons rose 9.2% between 2016–20 and 2021–25, driven largely by surging demand in Europe following Russia’s invasion of Ukraine, according to data released Monday by the Stockholm International Peace Research Institute. European countries more than tripled their arms imports during the period, making the region the largest recipient of international weapons trans...
Leestat Global transfers of major weapons rose 9.2% between 2016–20 and 2021–25, driven largely by surging demand in Europe following Russia’s invasion of Ukraine, according to data released Monday by the Stockholm International Peace Research Institute. European countries more than tripled their arms imports during the period, making the region the largest recipient of international weapons transfers. The increase helped push global arms flows to their highest levels since the mid-2010s. Ukraine alone accounted for 9.7% of global arms transfers between 2021 and 2025 as Western governments rushed weapons to support Kyiv’s defense. Many other European countries also increased procurement amid rising security concerns tied to Russia. “While tensions and conflicts in Asia and Oceania and the Middle East continue to drive large-scale arms imports, the sharp increase in arms flows to European states pushed global arms transfers up almost 10%,” Mathew George, director of SIPRI’s Arms Transfers Program, said in the announcement. U.S. exports surge The United States strengthened its position as the world’s dominant arms supplier during the period. U.S. exports rose 27%, giving it a 42% share of global arms transfers, up from 36% in the previous five-year period. American weapons shipments to Europe surged particularly sharply, rising 217%. For the first time in two decades, Europe accounted for the largest share of U.S. arms exports at 38%, slightly ahead of the Middle East at 33%. Saudi Arabia remained the single largest customer for U.S. weapons, receiving about 12% of American exports. “The USA has further cemented its dominance as an arms supplier, even in an increasingly multipolar world,” Pieter Wezeman, a senior researcher with the SIPRI Arms Transfers Program, said in the announcement. France ranked as the second-largest arms exporter, accounting for 9.8% of global shipments. French exports rose 21% during the period, with major customers including India, Egypt and ...
Alones Creative Hims & Hers ( HIMS ) and Novo Nordisk ( NVO ) have entered a collaboration in which the telehealth company will offer Novo’s GLP-1 weight loss drugs and stop marketing its compounded GLP-1 offerings. Hims & Hers will offer Novo Nordisk’s Ozempic (semaglutide) injections and Wegovy (semaglutide) pills and injections from later in March. The medication provider will continue to offer...
Alones Creative Hims & Hers ( HIMS ) and Novo Nordisk ( NVO ) have entered a collaboration in which the telehealth company will offer Novo’s GLP-1 weight loss drugs and stop marketing its compounded GLP-1 offerings. Hims & Hers will offer Novo Nordisk’s Ozempic (semaglutide) injections and Wegovy (semaglutide) pills and injections from later in March. The medication provider will continue to offer compounded GLP-1s to certain customers “if a provider determines that a compounded product is clinically necessary” but will not advertise compounded GLP-1 offerings on its platform or in its marketing. Novo Nordisk is concurrently dismissing its lawsuit against Hims & Hers ( HIMS ) without prejudice. The lawsuit had alleged infringement on a key U.S. patent related to semaglutide and came after a similar partnership collapsed in June 2025, when Hims & Hers declined to stop selling lower-cost compounded versions of Novo Nordisk’s ( NVO ) obesity drug. Shares of Hims & Hers ( HIMS ) rose as high as 50% in premarket hours on the news. More on Hims & Hers Health, Novo Nordisk A/S Hims & Hers Health: The Potential Deal With Novo Nordisk Is A Game-Changer CagriSema Incident: The Surprise Winner And What It Means For The Novo-Lilly Rivalry Hims & Hers Health: Leaving GLP-1s Behind Hims & Hers stock jumps on potential pact with Novo Nordisk Novo, Hims & Hers said to be eyeing a partnership to sell obesity drugs
(RTTNews) - Dentsply Sirona (XRAY) and Siemens Healthineers (SHL.DE) announced that the dental-dedicated ddMRI system - MAGNETOM Free.Max Dental Edition - has received FDA clearance. The companies said this follows the completion of a clinical trial validating the system's significant potential across multiple dental specialties. Dentsply Sirona stated that the clinical highlights from the trial d...
(RTTNews) - Dentsply Sirona (XRAY) and Siemens Healthineers (SHL.DE) announced that the dental-dedicated ddMRI system - MAGNETOM Free.Max Dental Edition - has received FDA clearance. The companies said this follows the completion of a clinical trial validating the system's significant potential across multiple dental specialties. Dentsply Sirona stated that the clinical highlights from the trial demonstrated MAGNETOM Free.Max Dental Edition's ability to differentiate active inflammation from healthy and scar tissue, enable non-invasive assessment of tooth pulp vitality to support chairside testing and observations and enables the visualization of teeth and their position in relation to neighboring teeth as well as the nerves. In pre-market trading on NasdaqGS, Dentsply Sirona shares are down 1.02 percent to $12.61. For More Such Health News, visit rttnews.com. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. What Baidu’s Recent Returns Tell You Baidu (NasdaqGS:BIDU) has seen mixed share performance, with a 0.9% gain over the past day, a 3.6% decline over the past week, and a larger pullback over the past month. Over the past 3 month...
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. What Baidu’s Recent Returns Tell You Baidu (NasdaqGS:BIDU) has seen mixed share performance, with a 0.9% gain over the past day, a 3.6% decline over the past week, and a larger pullback over the past month. Over the past 3 months, Baidu’s return has been negative, and year to date the stock is down about 20.8%, even as the 1 year total return stands at roughly 28.6%. See our latest analysis for Baidu. With the share price at $119.05, Baidu’s recent 1 month share price return of about an 18% decline and year to date weakness contrast with a stronger 1 year total shareholder return of roughly 28.6%, hinting that momentum has cooled after earlier gains. If Baidu’s recent AI focus has caught your attention, it could be a good time to widen your watchlist and check out 60 profitable AI stocks that aren't just burning cash as potential next ideas. So with Baidu’s share price under pressure recently, yet a roughly 29% 1-year total return on the board, is this a case of a discounted AI and search leader, or is the market already pricing in future growth? Most Popular Narrative: 60.4% Overvalued According to the most followed narrative, Baidu’s fair value of $74.22 sits well below the recent $119.05 share price, setting up a clear valuation gap for you to assess. Baidu presents a complex investment opportunity with substantial growth potential tied to its leadership in AI and emerging technologies. However, risks related to macroeconomic conditions, regulatory uncertainties, and execution challenges require a balanced approach. Strategic investors may evaluate Baidu’s potential in the context of its inherent risks and its ability to execute on AI-driven growth opportunities. Read the complete narrative. Curious how a company with mixed recent performance ends up with that kind of fair value gap? The narrat...